Description: In light of recent regulatory developments and international best practices, the Bermuda Monetary Authority has introduced proposed enhancements to the Bermuda regulatory framework for long-term commercial insurers. During this panel discussion, discuss the potential impacts of these proposed regulatory changes for existing commercial insurers and new entrants to the Bermuda life reinsurance market.

Description: As the size of the life reinsurance market in Bermuda has grown to over half a trillion dollars at the end of 2021, more and more actuaries are getting involved with this 21 square mile North Atlantic island in one way or the other. Come explore a fundamental understanding of the Bermuda solvency framework and an overview of its upcoming changes.

Description: This panel will take a holistic deep dive on the intersection of pending regulatory, actuarial, and technical developments in artificial intelligence (AI). Panelists will explore how AI and the diverse and evolving regulatory landscape surrounding this technology will impact actuaries' day-to-day jobs in managing risk, and what the (re)insurance industry is doing to leverage AI to streamline internal processes and simplify underwriting.

Description: This session will provide an update on regulatory changes and current hot topics in Bermuda. The speakers will update you on the most recent Bermuda regulatory reforms, including targeted enhancements to its regulatory capital framework, Own Risk and Insolvency Amendment (ORSA)/Commercial Insurer's Insolvency Self Assessment (CISSA) enhancements for climate risk assessment, and Bermuda corporate income tax changes to align with Global Minimum Tax.

Description: This webcast will walk through several statistical methods for imputing race and ethnicity from U.S. datasets, highlighting their strengths and weaknesses, talking about how to use them and evaluating their accuracy, and telling you where you can get code packages as well as a free dataset to try the methods out.

Description: Explore various aspects of the Asian reinsurance market in this webcast. Learn about the landscape within the market as speakers cover key topics like product perspectives, structured solutions and emerging trends and issues. Take an in-depth look at the post COVID-19 impact, as well as regulatory considerations that could affect the Asian reinsurance industry. Secure your spot in this opportunity and dive into the direction of this marketspace.

Description: Gene therapy is a quickly evolving field and will continue to grow as a risk concern for many health plans, stop loss insurers and reinsurers. Currently, there are only two approved gene therapies in the U.S., but that number is expected to escalate starting in the fall of 2022. Revisit the experience plans have had with the first two gene therapies, discuss plan design and network considerations in light of gene therapy, and discuss the actual composition of the near-term pipeline along with a range of modeled financial impacts and considerations for payers.

Description: The cell and gene therapy marketplace is quickly evolving and continues to grow as a risk concern for governments, health plans, stop loss insurers and reinsurers. In this webinar, we discuss currently approved tissue, cell and gene therapies, the near-term pipeline, uptake considerations, case management processes, plan document and contract considerations, risk mitigation processes and programs, and network considerations.

Description: This session will provide an update on regulatory changes and current hot topics in Bermuda. The speakers will update you on the most recent Bermuda regulatory reforms, including targeted enhancements to its regulatory capital framework, Own Risk and Insolvency Amendment (ORSA)/Commercial Insurer's Insolvency Self Assessment (CISSA) enhancements for climate risk assessment, and Bermuda corporate income tax changes to align with Global Minimum Tax.